These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11246453)

  • 1. Linking genotype to aorto-coronary atherosclerosis: a model using familial hypercholesterolemia and aorto-coronary calcification.
    Jensen JM; Kruse TA; Brorholt-Petersen JU; Christiansen TM; Jensen HK; Kolvraa S; Faergeman O
    Ann Hum Genet; 1999 Nov; 63(Pt 6):511-20. PubMed ID: 11246453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia.
    Brorholt-Petersen JU; Jensen HK; Jensen JM; Refsgaard J; Christiansen T; Hansen LB; Gregersen N; Faergeman O
    Clin Genet; 2002 Jun; 61(6):408-15. PubMed ID: 12121347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia.
    Descamps OS; Gilbeau JP; Luwaert R; Heller FR
    Eur J Clin Invest; 2003 Jan; 33(1):1-9. PubMed ID: 12492446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic calcifications in familial hypercholesterolemia: potential role of the low-density lipoprotein receptor gene.
    Alrasadi K; Alwaili K; Awan Z; Valenti D; Couture P; Genest J
    Am Heart J; 2009 Jan; 157(1):170-6. PubMed ID: 19081415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcifications in homozygote familial hypercholesterolemia.
    Awan Z; Alrasadi K; Francis GA; Hegele RA; McPherson R; Frohlich J; Valenti D; de Varennes B; Marcil M; Gagne C; Genest J; Couture P
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):777-85. PubMed ID: 18239150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic and phenotypic variation in familial hypercholesterolemia.
    Thompson GR; Seed M; Niththyananthan S; McCarthy S; Thorogood M
    Arteriosclerosis; 1989; 9(1 Suppl):I75-80. PubMed ID: 2912434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia.
    Ten Kate GJ; Neefjes LA; Dedic A; Nieman K; Langendonk JG; Galema-Boers AJ; Roeters van Lennep J; Moelker A; Krestin GP; Sijbrands EJ; de Feyter PJ
    Atherosclerosis; 2013 Apr; 227(2):334-41. PubMed ID: 23369702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
    Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
    J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
    Shin DG; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee JH; Lee SH
    Atherosclerosis; 2015 Nov; 243(1):53-8. PubMed ID: 26343872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutations.
    Versmissen J; Oosterveer DM; Hoekstra M; Out R; Berbée JF; Blommesteijn-Touw AC; van Vark-van der Zee L; Vongpromek R; Vanmierlo T; Defesche JC; Mulder M; Kastelein JJ; Sijbrands EJ
    Circ Cardiovasc Genet; 2011 Dec; 4(6):655-60. PubMed ID: 22010136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    Can J Cardiol; 2017 Oct; 33(10):1312-1318. PubMed ID: 28941610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia.
    Al Kindi M; Bélanger AM; Sayegh K; Senouci S; Aljenedil S; Sivakumaran L; Ruel I; Al Rasadi K; Al Waili K; Awan Z; Valenti D; Genest J
    Can J Cardiol; 2017 May; 33(5):658-665. PubMed ID: 28449836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia.
    Khan SP; Ghani R; Ahmed KZ; Yaqoob Z
    J Coll Physicians Surg Pak; 2011 Jul; 21(7):403-6. PubMed ID: 21777527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic changes in patients with heterozygous and homozygous familial hypercholesterolemia: correlation with clinical findings.
    Tatò F; Keller C; Schewe S; Pinter W; Wolfram G
    Bildgebung; 1991; 58(1):22-5. PubMed ID: 2070096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation.
    Schmidt HH; Tietge UJ; Buettner J; Barg-Hock H; Offner G; Schweitzer S; Dedoussis GV; Rodeck B; Kallfelz HC; Schlitt HJ; Oldhafer K; Klempnauer J
    Clin Transplant; 2008; 22(2):180-4. PubMed ID: 18339137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.
    Tada H; Kawashiri MA; Ohtani R; Noguchi T; Nakanishi C; Konno T; Hayashi K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
    Atherosclerosis; 2011 Dec; 219(2):663-6. PubMed ID: 21872251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
    Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
    J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.